| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |